Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 07-2002 | 04-2002 | 01-2002 | 10-2001 | 07-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 150 | 210 | 330 | 100 | 200 |
| Receivables | 160 | 590 | 500 | 530 | 570 |
| Inventories | 590 | 580 | 650 | 620 | 710 |
| Other current assets | 213 | 440 | 520 | 440 | 247 |
| TOTAL | $1,290 | $1,820 | $2,000 | $1,690 | $1,910 |
| Non-Current Assets | |||||
| PPE Net | 614 | N/A | N/A | N/A | 903 |
| Intangibles | 2,626 | 0 | 0 | 0 | 1,014 |
| Other Non-Current Assets | -611 | 2,899 | 2,899 | 1,308 | -669 |
| TOTAL | $2,629 | $2,899 | $2,899 | $1,308 | $1,248 |
| Total Assets | $4,540 | $5,450 | $5,690 | $3,840 | $4,060 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 590 | 720 | 520 | 350 | 540 |
| Accrued Expenses | 70 | 150 | 100 | 60 | 60 |
| TOTAL | $1,160 | $1,390 | $1,020 | $710 | $600 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,160 | $1,390 | $1,020 | $710 | $600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,098 | N/A | 991 | N/A | 872 |
| Common Shares | 13,970 | 13,600 | 13,620 | 11,670 | 11,510 |
| Retained earnings | -10,600 | -9,550 | -8,950 | -8,540 | -8,160 |
| Other shareholders' equity | 0 | 0 | -10 | 0 | 110 |
| TOTAL | $3,370 | $4,050 | $4,660 | $3,130 | $3,460 |
| Total Liabilities And Equity | $4,530 | $5,440 | $5,680 | $3,840 | $4,060 |